Related Experiment Video
Updated: Jun 17, 2026

05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
Multiple cerebral metastases as a primary presentation in papillary thyroid carcinoma
Andrew J Gauden1, Stanislaw J Gauden
1School of Medicine, University of Tasmania, Hobart, Tasmania, Australia. andrew.gauden@gmail.com
Summary
Cerebral metastases from papillary thyroid carcinoma are rare but aggressive. Early diagnosis and treatment, including surgery and radiation, can lead to favorable outcomes for these challenging brain tumors.
Area of Science:
- Neuro-oncology
- Endocrinology
- Oncology
Background:
- Cerebral metastases from papillary thyroid carcinoma (PTC) are uncommon but aggressive, often presenting with a poor prognosis.
- Papillary thyroid carcinoma is a common type of thyroid cancer, but its spread to the brain is a rare occurrence.
Observation:
- This report details a patient whose initial presentation of disseminated disease was multiple cerebral metastases.
- The patient's brain metastases were the first sign of her widespread papillary thyroid carcinoma.
Findings:
- The patient underwent surgical resection of the cerebral metastases.
- Following surgery, the patient received external beam radiotherapy and radioactive iodine therapy for treatment.
- The multimodal treatment approach was effective in managing the brain metastases.
Implications:
- Early detection and prompt intervention are crucial for managing cerebral metastases of papillary thyroid carcinoma.
- Aggressive management, including surgery and adjuvant therapies, can improve outcomes in patients with brain metastases from PTC.
- This case highlights the importance of considering rare metastatic sites in the diagnosis and treatment of thyroid cancer.
Related Concept Videos
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...

